Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Septerna, Inc. - Common Stock (NQ:SEPN)

20.60 -0.89 (-4.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160,221
Open 21.49
Bid (Size) 15.58 (1)
Ask (Size) 24.00 (1)
Prev. Close 21.49
Today's Range 20.03 - 21.49
52wk Range 4.170 - 28.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments 
Via MarketBeat
Topics World Trade
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
From Septerna, Inc.
Via GlobeNewswire

Performance

YTD
-3.5%
-3.5%
1 Month
+9.5%
+9.5%
3 Month
+66.0%
+66.0%
6 Month
+188.5%
+188.5%
1 Year
+1.1%
+1.1%

More News

Read More
Septerna to Participate in Upcoming Investor Conferences
From Septerna, Inc.
Via GlobeNewswire
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
From Septerna, Inc.
Via GlobeNewswire
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
From Septerna, Inc.
Via GlobeNewswire
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
Via Benzinga
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
The Analyst Verdict: Septerna In The Eyes Of 4 Experts
Via Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Via Investor's Business Daily
Septerna to Present at Jefferies Global Healthcare Conference
From Septerna, Inc.
Via GlobeNewswire
Analysts Think These Stocks Could More Than Double in Value
Via MarketBeat
Topics World Trade
Where Septerna Stands With Analysts
Via Benzinga
3 Stocks That Will Profit From Trump's Drug Price Cut
Via Benzinga
Topics Government
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
Via Benzinga
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
From Septerna, Inc.
Via GlobeNewswire
Which stocks have an unusual volume on Thursday?
Via Chartmill
Is It Time to Buy the Dip in Novo Nordisk Stock?
Via MarketBeat
Topics Government
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session.
Via Chartmill
Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Dow Edges Higher; US Crude Oil Inventories Increase
Via Benzinga
Topics Stocks
Wednesday's pre-market session: top gainers and losers
Via Chartmill
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs
Via Benzinga

Frequently Asked Questions

Is Septerna, Inc. - Common Stock publicly traded?
Yes, Septerna, Inc. - Common Stock is publicly traded.
What exchange does Septerna, Inc. - Common Stock trade on?
Septerna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Septerna, Inc. - Common Stock?
The ticker symbol for Septerna, Inc. - Common Stock is SEPN on the Nasdaq Stock Market
What is the current price of Septerna, Inc. - Common Stock?
The current price of Septerna, Inc. - Common Stock is 20.60
When was Septerna, Inc. - Common Stock last traded?
The last trade of Septerna, Inc. - Common Stock was at 10/31/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.